Alcidion Formally Launches Miya Precision as a New Kind of Technology for the NHS

Alcidion LtdA new type of technology for the NHS is expected to help re-energise the healthcare IT market, following the formal UK launch of Miya Precision by smart health tech company Alcidion.

Miya Precision integrates information from the healthcare organisation's current systems, uses it to automate routine tasks, care plans and pathways, and overlays existing data with advanced clinical decision support to make otherwise static information clinically valuable.

The new platform, which has been labelled as the very first smart clinical asset for the NHS, will provide hospitals and regions with a means to move beyond static electronic record systems to technology that proactively engages healthcare professionals.

The system will also immediately allow hospitals to realise clinical workflow benefits from clinical noting, natural language processing, electronic observations, electronic prescribing, flow management, mobility and more - to align with their digital strategies.

It will enable the NHS to quickly adopt new and emerging technologies and algorithms, as well as address strategic priorities. For example, integrated care systems are considering Miya Precision as an orchestration layer to join up disparate digital approaches and systems for hospitals across their regional footprint through a single smart interface. The platform does this by converting information in incumbent NHS systems to the FHIR standard - allowing that information to be applied to modern applications and to flow to appropriate users in a region.

Miya Precision has already seen early adoption in the NHS following successful use by organisations in other parts of the world and is expected to add significant value to existing electronic patient record strategies in the NHS. It will act as a core accelerator for trusts pursuing best of breed approaches to digitalisation.

Dartford and Gravesham NHS Trust is the first in the UK to sign up to Miya Precision. Neil Perry, director of digital transformation at the trust, said: "Miya Precision sits at the centre of our digital strategy. It provides a catalyst for us to harness digital technology in ways that allow our clinical staff to make informed decisions more easily, whilst focussing their time and efforts on delivering the best possible patient care and clinical outcomes. It is providing us with a new platform to become digitally mature, whilst leveraging artificial intelligence, natural language processing and many other advanced technologies. I look forward to sharing our approach with more hospitals considering this option."

Lynette Ousby, general manager for Alcidion in the UK, said: "We want to give the NHS a new option when it comes to technology that makes a difference to the way clinicians work. Miya Precision will automate care plans and pathways whilst relieving the cognitive burden still faced by healthcare professionals who very often still need to spend hours each day remembering to carry out hundreds of routine tasks.

"The NHS is faced with the challenge of delivering modern and engaging technology to clinicians whilst still needing to get value from its historic healthcare technologies. We believe we can offer an alternative to unlock that value, to join together systems and expose data in ways that really helps the people delivering care."

Alcidion is currently best known in the UK for its Patientrack early warning and electronic observations system. This system has helped hospitals in different parts of the UK to deliver a significant impact on patient safety by identifying and responding to the sickest patients and those at risk of deterioration. It has, for example, helped hospitals to deliver substantial reductions in cardiac arrests and to tackle deadly conditions including sepsis and acute kidney injury. As a more comprehensive solution, Miya Precision will help hospitals to build on this success and help to take technology adoption and patient safety in the NHS to the next level.

Dr Malcolm Pradhan, chief medical officer, for Alcidion, said: "Around the world the healthcare sector still expects doctors and nurses to perform acts of heroism every day just to get their job done. We believe IT systems should play a more active role in helping clinicians to look after their patients. Smart technology should help with the memory tasks so professionals can spend more time making difficult judgements - and then it should provide clinical decision support to aid in those decisions."

Alcidion Group managing director, Kate Quirke, said: "Formally launching Miya Precision for the NHS presents an opportunity for us to contribute to a history of world class excellence in enhancing patient care. The NHS is already Alcidion’s largest global partner of which we are immensely proud. We now look forward to using our full advanced product offering to help the health service accelerate its use of modern technology to support clinicians delivering care and to drive forward strategic priorities around interconnected and intelligent medicine."

About Alcidion

Alcidion Ltd (ASX:ALC) has a simple purpose, that is, to make healthcare better with smart, intuitive solutions that meet the needs of hospital and allied healthcare, worldwide. Alcidion incorporates three healthcare software companies previously known as Alcidion Corporation, Patientrack and OnCall and MKM Health, an IT solutions and services provider. Each company brings a complementary set of products and skills that create a unique offering in the global healthcare market; solutions that support interoperability, allow communication and task management, and deliver clinical decision support at the point of care to improve patient outcomes. With over 25 years of combined healthcare experience, the Alcidion Group of companies brings together the very best in technology and market knowledge to deliver solutions that make healthcare better for everyone.

Most Popular Now

73,000 Scientists Collaborate over New C…

More than 73,000 users collaborate on new online platform set up by the European Open Science Cloud Initiative, where scientists share COVID-19 data and accelerate our understanding of the virus...

Bayer and Informed Data Systems Inc. (On…

Bayer and Informed Data Systems Inc. (One Drop), a US-based digital health company, today announced that they have entered into an agreement to jointly develop digital health products for multiple...

ScanBalt Digital Forum 2020

4 September 2020, Germany. ScanBalt invites European cluster organisations to join the formulation of a joint declaration on the necessary next steps to create the Common European Health Data Space. Clusters...

C3-Cloud: the Digital Coordinated Care P…

Typically, when a patient is receiving care from GPs and Hospitals, these are normally uncoordinated and the patient is often presented with conflicting advice, or clinicians are required to assess...

Philips to Expand its Image-Guided Thera…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has signed an agreement to acquire Intact Vascular, Inc., a U.S.-based developer of medical...

Philips Launches New Innovations to Help…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today presented new approaches to health and healthcare, and the shift to health-at-home, at its virtual consumer health...

Innovation Improves Care Delivery Around…

Allscripts Healthcare Solutions (NASDAQ: MDRX) was recently awarded five separate patents over the course of just eight days, reflecting the company's commitment to delivering unique solutions to its clients and...

Alcidion Appointed to NHSX Clinical Comm…

NHSX has awarded smart health informatics provider Alcidion a place on the Clinical Communications Procurement Framework, a new procurement vehicle intended to help the NHS phase out pagers by the...

Contact Tracing Apps Unlikely to Contain…

Contract tracing apps used to reduce the spread of COVID-19 are unlikely to be effective without proper uptake and support from concurrent control measures, finds a new study by UCL...

Allscripts and Microsoft Extend Strategi…

Allscripts and Microsoft Corp. announced the extension of their long-standing strategic alliance to enable the expanded development and delivery of cloud-based health IT solutions. The five-year extension will support Allscripts...

Internet Searches for Anxiety Attacks Ta…

Many health experts are concerned that the COVID-19 pandemic could be having widespread effects on people's mental health, but assessing these concerns is difficult without data. "Traditional public health surveillance lacks...

Newly Merged CCG Expands Tech Support to…

Norfolk and Waveney Clinical Commissioning Group to support prescribers to improve the quality and safety of prescribing through deploying prescribing decision technology FDB OptimiseRx. A newly merged clinical commissioning group...